Alvogen plans to fight a court decision that could significantly delay its ability to bring a generic version of Bausch Health's Xifaxan to market, the company said.
READ MOREThe government said it “may consider future policy options” for anti-obesity medications, after declining to finalize a Biden-era proposal that would have expanded coverage to millions ...
READ MOREThe FDA is looking to further limit pharma companies' involvement in advisory committees that typically review new drugs or safety issues. But the shift away from pharma influence is likely ...
READ MOREWelcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.
READ MORE